Flanax

Description

Flanax-499 is a pharmaceutical formulation identified by its unique chemical composition. The active ingredient is formulated to provide therapeutic effects in the specified dosage form. The product exhibits a specific molecular weight, contributing to its pharmacokinetic properties. The structural formula is designed to ensure stability and efficacy. Flanax-499 is presented in a solid dosage form, characterized by its distinct appearance, which is consistent with industry standards for quality and safety. Inactive ingredients are included to facilitate the formulation and enhance the overall performance of the product.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, sprains, strains, and bruises.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older are instructed to apply the product to the affected area no more than 3 to 4 times daily. A temporary burning sensation may occur upon application; however, this typically subsides with continued use. It is essential to wash hands thoroughly after application to prevent the transfer of the liniment to the eyes or other sensitive areas. If the liniment is applied to the hands, it is recommended to wait 30 minutes before washing hands. Initial pain relief is generally observed within 1 to 2 weeks of use. If there is no improvement in the condition after 4 weeks, the use of this product should be discontinued.

For children under 12 years of age, it is advised to consult a healthcare professional before use.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to keep the product out of reach of children. In the event of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately.

Warnings and Precautions

For external use only. This product is contraindicated in individuals with known allergies to any of the active or inactive ingredients. It should not be applied to damaged, broken, or irritated skin, as this may exacerbate the condition or lead to adverse effects.

Caution is advised when using this product in conjunction with heat sources. It must not be used with a heating pad, nor should it be heated, microwaved, or added to hot water or any container with heating water, as this may cause splattering and result in burns. Additionally, the product should not be applied immediately before or after bathing or showering.

Healthcare professionals should instruct patients to discontinue use and seek medical advice if any of the following occur: the condition worsens, symptoms persist for more than 7 days, symptoms resolve and then recur within a few days, or if skin irritation develops.

While using this product, it is imperative to avoid contact with the lips, eyes, nose, and any mucous membranes. Bandaging the area of application is also not recommended, as this may alter the product's effectiveness and increase the risk of adverse reactions.

This product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Side Effects

Patients should be aware that this product is for external use only and should not be applied if there is a known allergy to any of the active or inactive ingredients. It is contraindicated for use on damaged, broken, or irritated skin, and should not be used in conjunction with a heating pad or immediately before or after bathing or showering.

In the event that the condition worsens, symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, patients are advised to discontinue use and consult a healthcare professional. Additionally, if skin irritation occurs, it is recommended to stop use and seek medical advice.

While using this product, patients must avoid heating, microwaving, or adding it to hot water, as this may cause splattering and result in burns. Contact with lips, eyes, nose, and any mucous membranes should be strictly avoided, and the product should not be bandaged.

It is crucial to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center should be made without delay.

Drug Interactions

There are no specific drug interactions reported for this medication. Additionally, no laboratory test interactions have been identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Flanax (methyl salicylate, menthol, capsaicin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and children aged 12 years and older, the recommended application is to the affected area not more than 3-4 times daily.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There are no specific warnings, precautions, or contraindications regarding pregnancy associated with the use of FLANAX (methyl salicylate, menthol, capsaicin liniment). Available data does not indicate any known risks to pregnant patients or adverse fetal outcomes related to the use of this product. However, as with any medication, healthcare professionals should consider the potential benefits and risks when prescribing FLANAX to women of childbearing potential. It is advisable to use caution and to discuss any concerns with patients who are pregnant or planning to become pregnant.

Lactation

There are no specific warnings or recommendations regarding the use of FLANAX liniment in nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants from the use of FLANAX liniment during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. Healthcare professionals are advised to seek medical help or contact a Poison Control Center without delay if the substance has been ingested.

Symptoms of overdosage may vary depending on the specific substance involved. It is essential for healthcare providers to assess the patient's condition and monitor for any adverse effects that may arise from the overdose.

Management of overdosage should be guided by the severity of symptoms and the specific substance involved. Supportive care and symptomatic treatment may be necessary, and healthcare professionals should follow established protocols for the management of overdose cases.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help immediately or contact a Poison Control Center for assistance. It is important for patients to understand the urgency of this situation to ensure their safety and well-being.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It should be stored at room temperature, within the range of 20° to 25°C (68° to 77°F). Care should be taken to ensure that the product is kept in a suitable container to maintain its integrity. Special handling requirements should be observed to prevent exposure to extreme temperatures or conditions that may compromise the product's quality.

Additional Clinical Information

Adults and children aged 12 years and older are advised to apply the product to the affected area no more than 3-4 times daily. Patients may experience a temporary burning sensation upon application, which typically subsides with continued use. It is important for patients to wash their hands thoroughly after use to prevent the liniment from coming into contact with the eyes or other sensitive areas. If the liniment is applied to the hands, patients should wait 30 minutes before washing their hands.

Initial pain relief is generally observed within 1-2 weeks of use. If there is no improvement in the condition after 4 weeks, patients should discontinue use of the product. For children under 12 years of age, consultation with a healthcare provider is recommended prior to use.

Drug Information (PDF)

This file contains official product information for Flanax, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)